Author Affiliations: Rutgers School of Nursing, Rutgers, The State University of New Jersey (Drs Nicholson, Flynn, Savage, and Zha); and Rutgers School of Public Health, Rutgers, The State University of New Jersey (Dr Kozlov).
Cancer Nurs. 2023;46(4):E253-E260. doi: 10.1097/NCC.0000000000001105. Epub 2023 Feb 7.
Cancer is the second leading cause of death in the United States. Patients with metastatic cancer have a high symptom burden. Major global and domestic cancer care recommendations advise integration of palliative care services for these patients. Palliative care is specialized care that can decrease cost, improve symptom burden, and improve quality of life. Patient factors driving the use of palliative care remain poorly understood but may include both physiological and psychological needs, namely, pain and depression, respectively.
The objective of this study was to identify patient-level predictors associated with inpatient palliative care use in patients with metastatic cancer.
This was a secondary analysis of the 2018 New Jersey State Inpatient Database. The sample was limited to hospitalized adults with metastatic cancer in New Jersey. Descriptive statistics characterized the sample. Generalized linear modeling estimated the effects of pain and depression on the use of inpatient palliative care.
The sample included 28 697 hospitalizations for patients with metastatic cancer. Within the sample, 4429 (15.4%) included a palliative care consultation. There was a 9.3% documented occurrence of pain and a 10.9% rate of depression. Pain contributed to palliative care use, but depression was not predictive of an inpatient care consultation. Age, income category, and insurance status were significant factors influencing use.
Understanding demographic and clinical variables relative to palliative care use may help facilitate access to palliative care for adults experiencing metastatic cancer.
Increased screening for pain and depression may expand palliative care use for adults with metastatic cancer receiving inpatient care.
癌症是美国的第二大死亡原因。转移性癌症患者的症状负担很高。主要的全球和国内癌症护理建议建议为这些患者整合姑息治疗服务。姑息治疗是一种专门的治疗方法,可以降低成本、减轻症状负担并提高生活质量。推动姑息治疗使用的患者因素仍了解甚少,但可能包括生理和心理需求,分别是疼痛和抑郁。
本研究的目的是确定与转移性癌症患者住院姑息治疗使用相关的患者层面预测因素。
这是对 2018 年新泽西州住院患者数据库的二次分析。样本仅限于新泽西州患有转移性癌症的住院成年人。描述性统计数据描述了样本特征。广义线性模型估计了疼痛和抑郁对住院姑息治疗使用的影响。
样本包括 28697 例转移性癌症患者的住院治疗。在样本中,4429 例(15.4%)包括姑息治疗咨询。有 9.3%的患者记录有疼痛,10.9%的患者有抑郁。疼痛与姑息治疗的使用有关,但抑郁不是住院护理咨询的预测因素。年龄、收入类别和保险状况是影响使用的重要因素。
了解与姑息治疗使用相关的人口统计学和临床变量可能有助于为接受住院治疗的患有转移性癌症的成年人提供姑息治疗。
增加对疼痛和抑郁的筛查可能会扩大接受住院治疗的转移性癌症成年人姑息治疗的使用。